Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Business First Bancshares Inc is a banks-regional business based in the US. Business First Bancshares shares (BFST) are listed on the NASDAQ and all prices are listed in US Dollars. Business First Bancshares employs 590 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$25.96|
|52-week range||$15.36 - $25.99|
|50-day moving average||$23.52|
|200-day moving average||$23.54|
|Wall St. target price||$29.88|
|Dividend yield||$0.44 (1.74%)|
|Earnings per share (TTM)||$2.56|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||2.45%|
|1 month (2021-09-23)||12.43%|
|3 months (2021-07-23)||13.07%|
|6 months (2021-04-23)||11.51%|
|1 year (2020-10-23)||51.28%|
|2 years (2019-10-23)||6.92%|
|3 years (2018-10-23)||2.85%|
|5 years (2016-10-19)||N/A|
Valuing Business First Bancshares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Business First Bancshares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Business First Bancshares's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Business First Bancshares shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$180.8 million|
|Operating margin TTM||38.33%|
|Gross profit TTM||$137.8 million|
|Return on assets TTM||1.28%|
|Return on equity TTM||13.02%|
|Market capitalisation||$519.9 million|
TTM: trailing 12 months
There are currently 124,711 Business First Bancshares shares held short by investors – that's known as Business First Bancshares's "short interest". This figure is 7.3% down from 134,485 last month.
There are a few different ways that this level of interest in shorting Business First Bancshares shares can be evaluated.
Business First Bancshares's "short interest ratio" (SIR) is the quantity of Business First Bancshares shares currently shorted divided by the average quantity of Business First Bancshares shares traded daily (recently around 36787.90560472). Business First Bancshares's SIR currently stands at 3.39. In other words for every 100,000 Business First Bancshares shares traded daily on the market, roughly 3390 shares are currently held short.
However Business First Bancshares's short interest can also be evaluated against the total number of Business First Bancshares shares, or, against the total number of tradable Business First Bancshares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Business First Bancshares's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Business First Bancshares shares in existence, roughly 10 shares are currently held short) or 0.0065% of the tradable shares (for every 100,000 tradable Business First Bancshares shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Business First Bancshares.
Find out more about how you can short Business First Bancshares stock.
Dividend payout ratio: 16.18% of net profits
Recently Business First Bancshares has paid out, on average, around 16.18% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Business First Bancshares shareholders could enjoy a 1.89% return on their shares, in the form of dividend payments. In Business First Bancshares's case, that would currently equate to about $0.44 per share.
While Business First Bancshares's payout ratio might seem low, this can signify that Business First Bancshares is investing more in its future growth.
Business First Bancshares's most recent dividend payout was on 30 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Over the last 12 months, Business First Bancshares's shares have ranged in value from as little as $15.362 up to $25.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Business First Bancshares's is 0.8489. This would suggest that Business First Bancshares's shares are less volatile than average (for this exchange).
Business First Bancshares, Inc. operates as the bank holding company for b1BANK that provides various banking products and services. It offers various deposit products and services, including a range of checking, demand, money market, time, and savings accounts, as well as certificates of deposit; and remote deposit capture and direct deposit services. The company also provides commercial and industrial loans, including commercial lines of credit, working capital loans, term loans, equipment financing, asset acquisition, expansion and development loans, borrowing base loans, letters of credit, and other loan products; construction and development loans; commercial real estate loans; residential real estate loans comprising first and second lien 1-4 family mortgage loans, and home equity lines of credit; and consumer loans, including secured and unsecured installment and term loans. In addition, it offers wealth management products, including mutual funds, annuities, individual retirement accounts, and other financial products. Further, the company provides a range of other financial services comprising drive-through banking facilities, automated teller machines, debit and credit cards, and employee and payroll benefits solutions; and night depository, personalized checks, treasury and cash management, merchant, automated clearing house, electronic funds transfer, domestic and foreign wire transfer, traveler's checks, vault, loan and deposit sweep accounts, lock-box, receivables factoring, correspondent banking, online and mobile banking, e-statements, and bank-by-mail services. The company operates approximately 42 full-service banking centers located in the State of Louisiana and in the Dallas/Fort Worth metroplex.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.